Dexcom (NSDQ:DXCM) topped estimates on Wall Street today with preliminary results for its fourth-quarter financial results. The San Diego, Calif.-based company said it expects to report $331 million in sales for the quarter ended Dec. 31 – up at least 50% from the same period last year. Get the full story at our sister site, Drug […]
Bovie Medical seeks new FDA indications for J-Plasma, Renuvion tech
Bovie Medical (NYSE:BVX) said today it submitted a 510(k) premarket notification to the FDA seeking expanded clearance for its J-Plasma and Renuvion technology. The Clearwater, Fla.-based company, which is looking to rebrand under the new moniker Apyx Medical Corporation beginning next year, said it is looking to clear the system for use in dermal resurfacing procedures. […]
FDA names Flatiron Health’s Abernethy as deputy commish | Personnel Moves, December 19, 2018
The FDA this week named Amy Abernethy, the chief medical officer for Roche subsidiary Flatiron Health, as principal deputy commissioner to replace Rachel Sherman, who is retiring in January. “She’s a highly regarded thought leader who has held numerous positions of leadership in her fields of interest and distinguished herself for her intellect, her passion […]
Bovie to rebrand as Apyx Medical, move to NASDAQ
Bovie Medical (NYSE:BVX) said yesterday that it plans to rebrand under the moniker Apyx Medical Corporation, effective January 1. In connection with the move, the Clearwater, Fla.-based company said that it is shifting its stock exchange listing from the New York Stock Exchange to the NASDAQ Global Select Market. The company plans to trade under the […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Philips board backs reappointment of CEO van Houten, CFO Bhattacharya | Personnel Moves – October 29, 2018
Royal Philips (NYSE:PHG) said today that its board of directors is backing the re-appointment of Frans van Houten as its president and CEO and Abhijit Bhattacharya as chief financial officer and board member. CEO van Houten has been at the head of Philips since 2011, while Bhattacharya joined the company in 2015, Amsterdam-based Philips said. During […]
Bovie Medical retools outlook
Bovie Medical (NYSE:BVX), fresh from the sale of its core electro-cautery business, saw its share price take a hit today after it updated its outlook for the rest of the year. Last month Bovie dealt its core business, including the Bovie brand, to Symmetry Surgical for $97 million. The all-cash sale augured a pivot for Clearwater, Fla.-based Bovie toward the cosmetic surgery […]
Bovie Medical closes $97m sale of core electro-cautery biz to Symmetry Surgical
Bovie Medical (NYSE:BVX) said today it closed the $97 million sale of its core electro-cautery business, including the Bovie brand, to Symmetry Surgical. The all-cash sale comes as Clearwater, Fla.-based Bovie looks to pivot toward the cosmetic surgery market, and includes transition services, patent licensing, disposables supply and generator manufacturing agreements. The deal also includes terms […]
Bovie Medical shares rise on Q1 sales Beat, closed enrollment of cosmetic J-Plasma IDE study
Shares in Bovie Medical (NYSE:BVX) rose today after the medical device maker beat sales expectations on Wall Street with its first quarter earnings release and announced that it closed enrollment of an FDA investigational device exemption study of its J-Plasma tech seeking a new cosmetic indication. The Clearwater, Fla.-based company posted losses of $935,000, or 3¢ […]
Bovie Medical launches Renuvion cosmetic surgery J-Plasma brand
Bovie Medical (NYSE:BVX) said yesterday it launched the Renuvion brand of cosmetic surgery devices using its J-Plasma technology. Through the newly launched brand, the Clearwater, Fla.-based company said it will sell devices powered by the J-Plasma technology specifically for the cosmetic surgery market. The J-Plasma device is a plasma-based cutter and coagulator that uses helium ionization […]
Bovie Medical launches IDE J-Plasma dermal skin resurfacing study
Bovie Medical (NYSE:BVX) said today it launched an FDA investigational device exemption clinical study of its J-Plasma surgical cutter, looking to explore the use of the device in dermal skin resurfacing. The first patient in the trial was enrolled by Dr. J. Holcomb at Sarasota, Fla.’s Institute for Integrated Aesthetics. The J-Plasma device is a plasma-based cutter […]
- 1
- 2
- 3
- …
- 5
- Next Page »
